| DB ID | MyCo_2472 |
| Title | Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients |
| Year | 2010 |
| PMID | 21087680 |
| Fungal Diseases involved | Invasive pulmonary aspergillosis |
| Associated Medical Condition | Patients with Hematologic Malignancies and Stem Cell Transplant Recipients |
| Genus | Aspergillus |
| Species | spp. |
| Organism | Aspergillus spp. |
| Ethical Statement | Patients with acute leukemia receiving chemother- apy or undergoing HSCT were eligible for this study, which was approved by, and performed according to the guidelines of the institutional review board at the University of Florida. |
| Site of Infection | None |
| Opportunistic invasive | Invasive |
| Sample type | Body fluid |
| Sample source | Bronchoalveolar lavage fluid (BALF) |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | GM |
| Biomarker Full Name | Galactomannan |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | USA |
| Cohort | A total of 107 BAL samples from 67 unique pa- tients were submitted for determination of GM index. |
| Cohort No. | 67 |
| Age Group | None |
| P Value | None |
| Sensitivity | 0.73 |
| Specificity | 0.89 |
| Positive Predictive Value | 0.73 |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | ELISA |
| Analysis Method | ELISA Based |
| ELISA kits | ELISA Kit- Platelia Aspergillus (Platelia Aspergillus EIA, Platelia Aspergillus; Bio-Rad, Edmonds, WA) |
| Assay Data | None |
| Validation Techniques used | FDA Approved -Platelia Aspergillus ELISA |
| Up Regulation Down Regulation | Increase |
| Sequence Data | None |
| External Link | None |
